Cancer metabolism specialist Agios Pharmaceuticals closes its initial public offering on Monday.
Agios Pharmaceuticals
Breaking News
Agios Pharmaceuticals, Inc released the details of the company's previously announced IPO.
Agios Pharmaceuticals Inc. revealed details for its market debut.
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Australian Farmer Prepares Grave of 3,000 Sheep After Failing to Find Buyer
- Tech Giants Gear Up for Earnings Showdown; Investors Await if AI Strategies Turned Into Profits
- Netflix Exceeds Projections with 9.33 Million New Subscribers in Q1, Hitting Nearly 270 Million Total
- Stability AI Cuts 10% of Its Workforce Following the Controversial Exit of Its CEO
- Trump Media Investors Finally See Uptick in Their Shares for 2 Straight Days
